"With the sense of urgency that we see today we have to very quickly ramp up," Cox said, though not without warning that doing anything with the virus takes time and great care because it is studied so little. And the protein the company held on to is not the virus, so it doesn't have to take the immense risks that other laboratories do when working on anything Ebola related.